Breast Cancer Trial, Recruiting NCT07021846 Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07021846
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with breast cancer confirmed by a tissue sample (biopsy) and have had breast-conserving surgery (surgery that removes the tumour but keeps most of the breast)
  • People who have had at least 3 small metal markers (called clips) placed inside the breast during surgery
  • People aged between 18 and 50 years old
  • People who have at least one of the following risk factors: cancer that has spread to nearby lymph nodes (N1), cancer cells found in blood or lymph vessels near the tumour (LVI), a large area of a specific type of cancer cells within the breast tissue (more than 25%), surgical margins that are very close to the tumour (less than 4 mm), cancer that does not respond to hormone treatments, or high-grade (grade 3) cancer
  • People who are generally well enough to carry out daily activities without much difficulty (confirm with trial site for exact fitness level required)
  • People whose blood test results show the bone marrow is producing enough blood cells — including red blood cells, white blood cells, and platelets — at levels above specific thresholds (confirm with trial site for exact values)

Who may not be able to join:

  • People who have previously had radiation treatment to the chest area
  • People who have cancer in both breasts at the same time
  • People who received chemotherapy before their surgery (known as neoadjuvant chemotherapy)
  • People with a Body Mass Index (BMI) over 35, which is a measure of body weight relative to height
  • People who have a connective tissue or collagen-related disease (such as lupus or scleroderma — confirm with trial site for exact conditions included)
  • People who are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +3906225418081

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Registry
ClinicalTrials.gov
Start date
12 March 2020
Est. completion
1 March 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Breast fibrosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov